BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 30385188)

  • 21. Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency.
    Nakajima K; Oshida H; Muneyuki T; Kakei M
    Core Evid; 2012; 7():77-91. PubMed ID: 22936895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency.
    ; Smith RC; Smith SF; Wilson J; Pearce C; Wray N; Vo R; Chen J; Ooi CY; Oliver M; Katz T; Turner R; Nikfarjam M; Rayner C; Horowitz M; Holtmann G; Talley N; Windsor J; Pirola R; Neale R
    Pancreatology; 2016; 16(2):164-80. PubMed ID: 26775768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Survival benefit of pancreatic enzyme replacement therapy in patients undergoing treatment of pancreatic neuroendocrine tumours.
    Thompson O; Hall L; Roberts K; Bradley E; Powell-Brett S; Pande R; Shah T
    HPB (Oxford); 2022 Nov; 24(11):1921-1929. PubMed ID: 35811220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of infants and toddlers with cystic fibrosis-related pancreatic insufficiency and fat malabsorption with pancrelipase MT.
    Van de Vijver E; Desager K; Mulberg AE; Staelens S; Verkade HJ; Bodewes FA; Malfroot A; Hauser B; Sinaasappel M; Van Biervliet S; Behm M; Pelckmans P; Callens D; Veereman-Wauters G
    J Pediatr Gastroenterol Nutr; 2011 Jul; 53(1):61-4. PubMed ID: 21694537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Pancreatic Enzyme Replacement Therapy on Patients With Advanced Pancreatic Adenocarcinoma: A Systematic Review and Narrative Synthesis.
    Landers A; Donaldson F; Brown H; McKenzie C; Pendharkar S
    Pancreas; 2022 May; 51(5):405-414. PubMed ID: 35973015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prescription patterns of pancreatic enzyme replacement therapy for patients with pancreatic cancer in the United States.
    Jain T; Sharma P; Giri B; Iyer S; Sethi V; Bava EP; Vaish U; Sahay P; Datta J; Reddy S; Bart Rose J; Khan A; Merchant N; Chari ST; Dudeja V
    HPB (Oxford); 2022 Oct; 24(10):1729-1737. PubMed ID: 35717430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Real-World Patient Experience With Pancreatic Enzyme Replacement Therapy in the Treatment of Exocrine Pancreatic Insufficiency.
    Barkin JA; Harb D; Kort J; Barkin JS
    Pancreas; 2024 Jan; 53(1):e16-e21. PubMed ID: 38039440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pancreatic Exocrine Insufficiency as a Complication of Gastrointestinal Surgery and the Impact of Pancreatic Enzyme Replacement Therapy.
    Chaudhary A; Domínguez-Muñoz JE; Layer P; Lerch MM
    Dig Dis; 2020; 38(1):53-68. PubMed ID: 31422398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
    Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
    Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
    de la Iglesia-García D; Huang W; Szatmary P; Baston-Rey I; Gonzalez-Lopez J; Prada-Ramallal G; Mukherjee R; Nunes QM; Domínguez-Muñoz JE; Sutton R;
    Gut; 2017 Aug; 66(8):1354-1355. PubMed ID: 27941156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis.
    Iglesia D; Avci B; Kiriukova M; Panic N; Bozhychko M; Sandru V; de-Madaria E; Capurso G
    United European Gastroenterol J; 2020 Nov; 8(9):1115-1125. PubMed ID: 32631175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic Enzyme Replacement Therapy in Patients with Non-pancreatic Digestive Conditions: A Nationwide Claims Analysis.
    Phillips AE; Tang G; Wang X; Forsmark CE; Yadav D
    Dig Dis Sci; 2023 May; 68(5):1754-1761. PubMed ID: 36370243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exocrine Pancreatic Insufficiency Dosing Guidelines for Pancreatic Enzyme Replacement Therapy Vary Widely Across Disease Types.
    Lewis DM; Rieke JG; Almusaylim K; Kanchibhatla A; Blanchette JE; Lewis C
    Dig Dis Sci; 2024 Feb; 69(2):615-633. PubMed ID: 38117426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dependence of PERT endpoint on endogenous lipase activity.
    Gao WY; Mulberg AE
    Pancreas; 2014 Nov; 43(8):1232-8. PubMed ID: 25102439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic enzyme supplementation.
    Wier HA; Kuhn RJ
    Curr Opin Pediatr; 2011 Oct; 23(5):541-4. PubMed ID: 21799412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gut microbiome as a response marker for pancreatic enzyme replacement therapy in a porcine model of exocrine pancreas insufficiency.
    Ritz S; Hahn D; Wami HT; Tegelkamp K; Dobrindt U; Schnekenburger J
    Microb Cell Fact; 2020 Dec; 19(1):221. PubMed ID: 33272255
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycemic Variability Assessment in Newly Treated Exocrine Pancreatic Insufficiency With Type 1 Diabetes.
    Lewis DM; Shahid A
    J Diabetes Sci Technol; 2024 Mar; 18(2):430-437. PubMed ID: 35787705
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fecal fat and energy loss in pancreas exocrine insufficiency: the role of pancreas enzyme replacement therapy.
    Erchinger F; Øvre AKN; Aarseth MM; Engjom T; Brønstad I; Dimcevski G; Gudbrandsen OA; Tjora E
    Scand J Gastroenterol; 2018 Sep; 53(9):1132-1138. PubMed ID: 30193081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.